Quality Assurance and Regulatory Affairs (QARA) Trends in Medical Devices

Download↗Talk to us

Authors

Marut Setia profile photo

Marut Setia

Amit Mohan profile photo

Amit Mohan

Sabitha Aboo profile photo

Sabitha Aboo

This study’s goal is to assess the key areas of prioritization of medical device manufacturers in their quality and regulatory affairs. It enables medical device quality assurance and regulatory affairs leaders to understand and plan for challenges and trends in the industry with QARA Trendspeer-driven insights. It empowers them with practical recommendations to set up best in class operations for quality management system compliance, regulatory compliance, risk management and enhanced post market surveillance activities to elevate organizational effectiveness and efficiency.

100 leaders across Quality Assurance and Regulatory Affairs (QARA) functions participated in this study conducted between April 26, 2023 and May 15, 2023. Some survey questions included multiple selection options, so totals do not always add up to 100.

Quality Assurance and Regulatory Affairs leaders across company sizes and therapies participated in the study

Company's approximate revenue (in USD) globally for the calendar year 2022 of the respondents
Percentage wise therapeutic areas QARA leaders focus on

A broad range of manufacturers participated in the study

Percentage wise type of medical devices respondents company's manufacture
Percentage wise class of medical devices respondents company's manufacture

Senior QARA leaders with global responsibility participated in the study

Percentage wise representation of QARA leaders function who participated in the study
Percentage wise representation of QARA leaders current designation who participated in the study
Percentage wise representation of QARA leaders regional responsibility who participated in the study

Technology, QMS and supplier quality are the top 3 priorities for QARA leaders

Majority of QARA medical devices leaders call out leveraging technology (47%), implementing or upgrading QMS and processes (39%) and improving supplier quality and processes (34%) amongst their top 3 priorities. While compliance with regulations remains table stakes, there is now a strong drive toward process modernization and digital enablement to elevate speed, accuracy, and efficiency. Accelerating regulatory approvals and improving patient safety also feature prominently—highlighting the dual mandate QARA leaders face: to ensure compliance while enabling innovation and safe market access.

Chart illustrating top QARA priorities in medical devices: technology for agility, QMS upgrades, and supplier quality enhancements.

Deficiency reports, customer complaints and CAPA are the top 3 KPIs

For most QARA leaders, when it comes to evaluating performance, traditional KPIs such as deficiency reports (45%), customer complaints (45%), and CAPA (43%) remain central. Adverse events and recalls (39%) is another important KPI measured by QARA leaders.

However, there is growing emphasis on first-pass submission quality, reflecting a shift toward measuring effectiveness not only in terms of compliance but in reducing rework and streamlining approvals. This evolution signals that QARA teams are maturing—pivoting from retrospective performance checks to KPIs that support faster, more accurate, and scalable product submissions.

Top KPIs for QARA impact: Number of deficiency reports, customer complaints, CAPAs, and certification timelines

71% of QARA leaders are cautious about achieving their goals

Percentage wise confidence in current quality assurance and regulatory affairs to achieve goals

Traceability, siloed information and regulatory changes challenge leaders

QARA leaders continue to face significant challenges across maintaining traceability (45%), data integration (41%), and regulatory change management (37%). Leaders cite fragmented systems, siloed information, and the growing volume of documentation as critical pain points that hinder speed and accuracy. Compounding this is the increasingly dynamic nature of regulatory environments—especially in fast-evolving markets. Many teams struggle to maintain consistent compliance while adapting to shifting local regulations and global harmonization efforts. More leaders call out the huge amount of documentation (13%) as their number 1 challenge than budget constraints (12%).

Bar chart ranking top challenges to achieving goals in life sciences, with traceability, information silos, and regulatory changes as leading concerns.

Most leaders increased their budget versus last year

76% of leaders witnessed an increase in their budget versus last year. Only 6% had a lower budget versus last year. 56% of leaders increased their budget by up to 10%. Another 20% of them increased their budget by more than 10%.

Percentage wise change in budget compared to last year

43% leaders submitted 5+ products for submissions in past 12 months

While the volume of submissions varies by organization size and market focus, the overall trend indicates that regulatory operations are scaling. Companies are increasingly managing multiple submissions across diverse geographies, each with unique regulatory nuances.

43% of leaders submitted more than five products for regulatory approval in the past 12 months. A few large companies (with sales exceeding $10 billion) submitted over 50 products during the same period.

Percentage wise product submitted for approval in last 12 months response by QARA leaders

51% leaders planning 5+ products for submissions in next 12 months

Looking ahead, 51% of leaders surveyed are planning regulatory submissions for more than 5 products over the next 12 months. Few large companies (sales >$10 billion) planning over 50 products for regulatory submissions over the next 12 months.

Manufacturers get a wide range of data deficiency questions

45% of manufacturers get more than 10 clarifications or data deficiency questions for each regulatory submission. Few large companies (sales >$10 billion) get more than 10 clarifications or data deficiency questions for each regulatory submission.

Percentage wise clarification or data deficiency questions for each regulatory submission

Most companies partner with service providers to manage submissions

46% of the manufacturers surveyed partner with external service providers on a needs-basis while 42% manage Regulatory Intelligence— A Key to Successful Submissionsregulatory submissions with in-house capabilities.

Percentage wise managing regulatory submissions and registrations around the world

eQMS and regulatory intelligence platform are the most adopted technologies

Among digital tools, electronic Quality Management Systems (eQMS) and regulatory intelligence platforms are leading the way in adoption. 68% of QARA leaders are scaling adoption or using automated / eQMS systems as a way of life. 62% of them use regulatory intelligence platforms often. 44% of leaders are piloting automated literature screening for clinical evaluation, while 35% of them are trying out Indegene Unlocks 20- 30% Productivity Enhancement in EU-MDR Complianceautomated technical documentation compilation for EU MDR compliance.

Chart showing adoption of regulatory tech, with regulatory intelligence platforms widely used and eQMS systems actively scaling

QARA leaders can improve the effectiveness and efficiency of their operations through the following ways

Create technology-led information radiators to drive agility and accountability

Adopt an eQMS to maintain traceability and consistency and improve accuracy of your data. Get stronger visibility into your quality data so you can monitor and analyze crucial information effectively. The improved data accessibility enables you to improve accountability and find product discrepancies and deficiencies upstream, reduces probability of customer complaints and notified body deficiency reports.

Enhance productivity through AI-based tools to write device technical documents and maintain consistency

Adopt automated software for Navigating Content Management Challenges in the MedTech Manufacturing Industryliterature surveillance and content authoring for technical documentation. Learning AI systems help you streamline information lying across the DHF (Design History File) and DMR (Device Master Record) to ensure consistency and a single source of truth and improve productivity up to 50%.

Document Search and Summarization in Life Sciences with Generative AIRead more about Revolutionizing Document Search and Summarization in Life Sciences with Generative AI.

Manage supplier quality through a risk-based approach just like an internal component

Establish critical-to-quality and critical-to-safety specifications for the product. Ensure that these requirements flow down to every component, including the components that suppliers would provide. Assess and mitigate safety risks through a Hazard Evaluation & Risk Analysis Processscientific risk-evaluation-process. Perform supplier training and monitor training compliance.

Break silos with cross-functional platform or technology that integrates existing isolated systems

Facilitate cross-functional automation, share data seamlessly and access to files and documents on mobile by adopting relevant technology. Use a platform that breaks down silos and supports cross-functional operations (such as warehouse management, production, procurement, medical device quality control, and shipping) to improve decision-making and speed-to-market.

Manage ever-changing regulatory environment with an Assess-Address-Act methodology

Communication on regulation changes is huge, distributed and daunting to derive actionable insights from. Adopt the Assess-Address-Act methodology to improve turnaround time. Assess: Leverage technology to scan and ingest data regularly from internal and external sources, auto-tag regulatory data based on predefined taxonomy, and interpret data to drive insights. Address: Make Indegene Accelerates Remediation of Client’s QMS, Ensuring 100% Compliancechanges to QMS procedures, guidelines and templates. Update product documentation in line with QMS changes. Adopt technology to determine lineage of documents to ensure consistency and accuracy. Act: Perform internal and external audits to ensure regulations are implemented correctly.

Download↗Talk to us

Authors

Marut Setia profile photo

Marut Setia

Amit Mohan profile photo

Amit Mohan

Sabitha Aboo profile photo

Sabitha Aboo